Anyone who took Zantac (ranitidine) and was diagnosed with cancer.
What’s Going On?
Allegations have surfaced that Zantac’s manufacturer knew that the drug could cause cancer but failed to warn doctors and patients about the risk. Attorneys working with ClassAction.org are now investigating whether they can file lawsuits on behalf of Zantac users who were diagnosed with cancer.
How Could a Lawsuit Help?
A lawsuit could help recover money for medical bills, physical pain and other damages.
How Much Does an Attorney Cost?
Most attorneys handling these cases will only get paid if they win your case. Further, it costs nothing to speak with an attorney about your rights.
Lawsuits have been filed alleging that Sanofi-Aventis, maker of Zantac, failed to warn users that the medicine could produce unsafe levels of a probable carcinogen after being ingested.
Attorneys working with ClassAction.org are now investigating whether more lawsuits can be filed on behalf of Zantac users who were diagnosed with cancer. The lawsuits, if successful, could help pay for medical expenses and other damages associated with taking Zantac.
Why Were Lawsuits Filed?
The first lawsuits were filed after online pharmacy Valisure notified the FDA that it had detected “extremely high levels” of a probable carcinogen known as n-nitrosodimethylamine (NDMA) in “every lot tested, across multiple manufacturers” of ranitidine products, including Zantac.
According to Valisure, an “inherent instability” in ranitidine can cause it to react with itself to produce NDMA. Testing performed by the pharmacy detected more than 3 million nanograms of NDMA per tablet, which amounts to more than 31,000 times the FDA’s maximum daily intake limit.
The lawsuits are arguing that Zantac’s manufacturer, Sanofi, knew Zantac could convert to NDMA in the body, yet failed to warn users about the serious health risks—including cancer—that came with taking the medicine.
Did Zantac Get Recalled?
Yes. On April 1, 2020, the FDA requested that manufacturers immediately recall all prescription and over-the-counter (OTC) ranitidine medications.
According to the FDA, testing has revealed that NDMA levels in ranitidine drugs increase over time “even under normal storage conditions” and especially in warmer temperatures. The testing also showed that the older the product is, the greater the level of NDMA it contained, the agency said.
The FDA recommends that consumers stop taking OTC ranitidine products and dispose of the drugs. The agency also stated that those taking prescription products should speak to their healthcare providers before stopping the medicine.
According to the FDA, ranitidine medication, including Zantac, “should not be available to consumers and patients unless its quality can be assured.”
Are These Class Action Lawsuits?
Although class action lawsuits have been filed over Sanofi’s alleged misrepresentations of Zantac as “safe and effective,” those lawsuits are typically seeking to repay users for the money they spent on the medicine itself—and not any damages associated with developing cancer.
Attorneys working with ClassAction.org are looking to file individual lawsuits on behalf of Zantac users who were diagnosed with cancer, including but not limited to bladder, stomach, breast, kidney, prostate, esophageal, lung, colorectal, liver and pancreatic cancer.
What Can I Get From a Lawsuit?
Zantac users may be able to recover money for the following in a successful case:
In the case of death, family members may also be able to collect money for funeral expenses, loss of expected earnings, and loss of companionship.
How Much Does an Attorney Cost?
Attorneys working with ClassAction.org are handling these cases on what’s known as a contingency-fee basis. This means they will only get paid if they win your case. In these instances, they will typically collect a portion of your settlement or judgment.
How Do I Start?
If you took Zantac and were diagnosed with cancer, fill out the form on this page. An attorney may contact you directly to tell you more about the litigation and answer your questions.